Fondazione Penta Ets — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

0 Recruiting

1 Completed trials

3 Countries active

11 Unique IMPs

100% Results reported

Phase III

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

Top indications

2 total

Pregnancy and Infant PrEparedness pLatform IN Europe (PIPELINE)-RSV immunisation adaptive platform trial (PIPELINE-RSV) Pending

2025-522194-11-00 Phase III 2 countries NIRSEVIMAB; RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, STABILIZED PREFUSION F PROT…
A randomised non-inferiority trial with nested PK to assess DTG/3TC fixed dose formulations for the maintenance of virological suppression i… Ended

2024-520388-15-00 Phase III 1 country ABACAVIR SULFATE; ABACAVIR SULFATE, LAMIVUDINE; ABACAVIR SULFATE, LAMIVUDINE, DO…

Showing 1–2 of 2 trials